↓ Skip to main content

The Effect of Once-Daily Gabapentin Extended Release Formulation in Patients With Postamputation Pain

Overview of attention for article published in Frontiers in Pharmacology, May 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Effect of Once-Daily Gabapentin Extended Release Formulation in Patients With Postamputation Pain
Published in
Frontiers in Pharmacology, May 2019
DOI 10.3389/fphar.2019.00504
Pubmed ID
Authors

Nebojsa Nick Knezevic, Tabish Aijaz, Kenneth D. Candido, Svetlana Kovaleva, Alexei Lissounov, Ivana Knezevic

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 21%
Student > Bachelor 2 14%
Student > Doctoral Student 1 7%
Professor 1 7%
Student > Master 1 7%
Other 1 7%
Unknown 5 36%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 21%
Arts and Humanities 1 7%
Nursing and Health Professions 1 7%
Agricultural and Biological Sciences 1 7%
Medicine and Dentistry 1 7%
Other 1 7%
Unknown 6 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2019.
All research outputs
#8,814,955
of 26,208,484 outputs
Outputs from Frontiers in Pharmacology
#4,259
of 20,167 outputs
Outputs of similar age
#147,720
of 368,271 outputs
Outputs of similar age from Frontiers in Pharmacology
#144
of 345 outputs
Altmetric has tracked 26,208,484 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 20,167 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,271 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 345 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.